Medindia LOGIN REGISTER
Medindia

Biomarkers can Reveal Timing for Cancer Drugs to Act

A biomarker named CD109 that can visualize blood vessel activity can optimize the timing of anticancer therapies including anti-angiogenics. Tumor growth needs the formation of new blood vessels (angiogenesis). Angiogenesis inhibitors alone have failed to invoke significant response rates or prolong survival in solid tumor patients.

Advertisement
Advertisement
Advertisement

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education

Consumer

Professional